Connection
Lu Huang to Leishmaniasis, Cutaneous
This is a "connection" page, showing publications Lu Huang has written about Leishmaniasis, Cutaneous.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.670 |
|
|
|
-
Huang L, Hinchman M, Mendez S. Coinjection with TLR2 agonist Pam3CSK4 reduces the pathology of leishmanization in mice. PLoS Negl Trop Dis. 2015 Mar; 9(3):e0003546.
Score: 0.494
-
Wu W, Huang L, Mendez S. A live Leishmania major vaccine containing CpG motifs induces the de novo generation of Th17 cells in C57BL/6 mice. Eur J Immunol. 2010 Sep; 40(9):2517-27.
Score: 0.090
-
Mendez S, Traslavina R, Hinchman M, Huang L, Green P, Cynamon MH, Welch JT. The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells. Antimicrob Agents Chemother. 2009 Dec; 53(12):5114-21.
Score: 0.085